首页> 外国专利> 2,3-DIHYDRO-1H-INDEN-1-ONE DERIVATIVES AS RETINOIC ACID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA) ANTAGONISTS FOR TREATING MULTIPLE SCLEROSIS

2,3-DIHYDRO-1H-INDEN-1-ONE DERIVATIVES AS RETINOIC ACID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA) ANTAGONISTS FOR TREATING MULTIPLE SCLEROSIS

机译:2,3-二氢-1H-茚-1-酮衍生物与视黄酸相关的奥尔潘受体伽玛(ROR GAMMA)拮抗剂,用于治疗多发性硬化症

摘要

The present invention is directed to compounds, their synthesis, and their use as antagonists, inverse agonists, modulators and or inhibitors of the Retinoic acid-related orphan nuclear receptor t (RORt)/ROR. The compounds of the present invention are useful for modulating RORt)/ROR activity and for treating diseases or conditions mediated by RORt)/ROR such as for example, disease states associated with immunopathology of human autoimmune diseases such as Multiple Sclerosis (MS), Rheumatoid Arthritis (RA), Inflammatory Colitis, Psoriasis, COPD, Pain, Obesity, Diabetes, Dyslipidemia, Osteoporosis, Asthma, Neurodegenerative diseases and Cancer.
机译:本发明涉及化合物,其合成以及它们作为视黄酸相关孤儿核受体t(RORt)/ ROR的拮抗剂,反向激动剂,调节剂或抑制剂的用途。本发明的化合物可用于调节RORt)/ ROR活性并用于治疗由RORt)/ ROR介导的疾病或病症,例如与人类自身免疫疾病如多发性硬化症(MS),类风湿病的免疫病理学相关的疾病状态。关节炎(RA),炎性结肠炎,牛皮癣,COPD,疼痛,肥胖症,糖尿病,血脂异常,骨质疏松症,哮喘,神经退行性疾病和癌症。

著录项

  • 公开/公告号EP3044223B1

    专利类型

  • 公开/公告日2020-04-01

    原文格式PDF

  • 申请/专利权人 ARRIEN PHARMACEUTICALS LLC;

    申请/专利号EP20140844892

  • 申请日2014-08-28

  • 分类号C07C323/22;C07D211/14;C07D211/38;C07D211/58;C07D213/50;C07D231/12;C07D277/42;C07D295/116;C07D295/135;C07D401/10;A61P17/06;A61P35;A61P37;A61K31/5377;

  • 国家 EP

  • 入库时间 2022-08-21 11:42:40

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号